Key Points
- Director Gtcr Investment Xi Llc sold 12.7 million shares of Sotera Health on May 13 at an average price of $15.17, totaling about $193.2 million.
- The sale follows another large insider transaction earlier in the year, when the same entity sold 10 million shares on March 6 for about $152.7 million.
- Sotera Health recently reported better-than-expected quarterly results, with EPS of $0.18 and revenue of $280.05 million, while analysts currently rate the stock a Moderate Buy with an average price target of $20.33.
Sotera Health Company (NASDAQ:SHC - Get Free Report) Director Gtcr Investment Xi Llc sold 12,735,301 shares of the business's stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total value of $193,194,516.17. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Gtcr Investment Xi Llc also recently made the following trade(s):
- On Friday, March 6th, Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock. The shares were sold at an average price of $15.27, for a total value of $152,700,000.00.
Sotera Health Trading Down 1.4%
NASDAQ SHC opened at $15.27 on Friday. The stock has a market capitalization of $4.35 billion, a price-to-earnings ratio of 37.24 and a beta of 1.82. The stock's 50 day moving average price is $14.88 and its two-hundred day moving average price is $16.43. The company has a debt-to-equity ratio of 3.56, a quick ratio of 2.54 and a current ratio of 2.82. Sotera Health Company has a 52 week low of $10.80 and a 52 week high of $19.85.
Sotera Health (NASDAQ:SHC - Get Free Report) last released its earnings results on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.17 by $0.01. The firm had revenue of $280.05 million for the quarter, compared to analysts' expectations of $270.78 million. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The business's quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.14 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. As a group, analysts anticipate that Sotera Health Company will post 0.86 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Several research analysts have weighed in on the company. Wall Street Zen lowered Sotera Health from a "strong-buy" rating to a "buy" rating in a research report on Saturday, April 11th. Zacks Research lowered Sotera Health from a "strong-buy" rating to a "hold" rating in a research report on Friday, January 30th. Citigroup boosted their price target on Sotera Health from $21.00 to $23.00 and gave the stock a "buy" rating in a research report on Tuesday, February 24th. Barclays lowered their price target on Sotera Health from $20.00 to $18.00 and set an "overweight" rating on the stock in a research report on Tuesday, April 14th. Finally, Piper Sandler reaffirmed an "overweight" rating and set a $22.00 price target (down from $24.00) on shares of Sotera Health in a research report on Wednesday, May 6th. Seven analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, Sotera Health presently has an average rating of "Moderate Buy" and an average price target of $20.33.
Get Our Latest Stock Report on SHC
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in SHC. Empowered Funds LLC increased its holdings in shares of Sotera Health by 11.1% during the 1st quarter. Empowered Funds LLC now owns 28,512 shares of the company's stock worth $332,000 after acquiring an additional 2,845 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Sotera Health by 14.5% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 342,934 shares of the company's stock worth $3,999,000 after acquiring an additional 43,471 shares during the last quarter. Acadian Asset Management LLC increased its holdings in shares of Sotera Health by 125.5% during the 1st quarter. Acadian Asset Management LLC now owns 25,192 shares of the company's stock worth $293,000 after acquiring an additional 14,018 shares during the last quarter. Creative Planning increased its holdings in shares of Sotera Health by 15.3% during the 2nd quarter. Creative Planning now owns 20,186 shares of the company's stock worth $224,000 after acquiring an additional 2,673 shares during the last quarter. Finally, Invesco Ltd. increased its holdings in shares of Sotera Health by 4.2% during the 2nd quarter. Invesco Ltd. now owns 319,156 shares of the company's stock worth $3,549,000 after acquiring an additional 12,758 shares during the last quarter. 91.03% of the stock is owned by institutional investors and hedge funds.
Sotera Health Company Profile
(
Get Free Report)
Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.
Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
